If you train at sea level while wearing a resistance breathing mask, your SpO2 does not drop, your EPO does not rise, and you are not adapting to altitude in any measurable sense. But that does not mean the mask does nothing.
The altitude mask debate has produced a lot of heat and very little clarity — largely because it conflates two entirely separate mechanisms.
---
True altitude adaptation — live high train low (LHTL) — requires continuous exposure to hypoxic air at elevations above 2,400 metres for 12–16 hours per day over 3–4 weeks. The mechanism is well understood: reduced partial pressure of oxygen lowers SpO2, which activates HIF-1α (hypoxia-inducible factor), which drives erythropoietin (EPO) secretion from the kidneys, which stimulates erythropoiesis — increasing haematocrit and haemoglobin mass over 3–4 weeks. The result is a 5–7% VO2max improvement that partially persists for 2–3 weeks at sea level.
A training mask worn at sea level does none of this. The restriction is mechanical, not chemical. The inspired air passing through a mask valve is still 21% oxygen. Porcari and colleagues (2016, Journal of Sports Science and Medicine) tested this directly: 24 participants completed a 6-week protocol wearing an elevation mask or no mask during training. VO2max, respiratory compensation point and time to exhaustion did not differ between groups. Critically, SpO2 during mask exercise was no lower than 98% — indistinguishable from unmasked exercise.
---
However, the same study found a significant improvement in respiratory muscle strength and endurance — maximum inspiratory pressure and maximum voluntary ventilation — in the mask group. This is a real, measurable adaptation. It is just inspiratory muscle training (IMT), not altitude adaptation.
IMT is a legitimate performance intervention with its own evidence base. Dempsey and colleagues (2006) demonstrated that the respiratory muscles compete with locomotor muscles for cardiac output during maximal exercise via the locomotor metaboreflex: fatigued inspiratory muscles trigger sympathetic vasoconstriction in active leg musculature, diverting blood away from working fibres. Training the diaphragm and intercostals to resist fatigue delays this reflex.
Romer and colleagues (2002, Medicine and Science in Sports and Exercise) showed that 6 weeks of threshold IMT using a POWERbreathe device improved 20km and 40km cycling time trial performance by 4.6% and 4.5% respectively in trained cyclists. Witt and colleagues (2007) confirmed IMT accelerated whole-body VO2 kinetics at the onset of heavy exercise — reducing the oxygen deficit and lowering perceived effort at given intensities.
---
The key distinction:
- Want altitude adaptation? Book a hypoxic tent, a high-altitude training camp, or a commercial LHTL facility. Masks do not deliver this.
- Want inspiratory muscle training? A resistance breathing mask or a dedicated POWERbreathe/Expand-a-Lung device will work — but the mask is not superior to a purpose-built IMT device, and a purpose-built device allows precise load titration.
For athletes wanting to know where their aerobic ceiling actually sits and track genuine adaptations — whether from LHTL camps, block periodisation or IMT protocols — rather than the marketing claims of training accessories, the free estimator at winsport.uk/tools/performance/vo2-max-calculator provides a field-validated VO2max estimate you can retest across training cycles to track real change.
Have you used respiratory muscle training (mask or IMT device) and noticed a difference in breathing comfort at threshold efforts?